1

Bococizumab: A Deep Dive into RN316 and Related Compounds

bococizumab081041
RN316, a key compound for the bococizumab development program, represents a significant area of research for targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). Related compounds, often referred to as https://www.targetmol.com/compound/bococizumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story